[EN] PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION<br/>[FR] DÉRIVÉS DE PHÉNYL-N-QUINOLÉINE POUR LE TRAITEMENT D'UNE INFECTION PAR UN VIRUS À ARN
申请人:ABIVAX
公开号:WO2020011810A1
公开(公告)日:2020-01-16
The present invention relates to a compound of formula (I) or any of its pharmaceutically acceptable salt for use in the treatment and/or prevention of a RNA virus infection, and in particular a RNA virus infection from group IV or V of the Baltimore classification, formula (I), wherein R3 represents a chlorine atom or a hydrogen atom, R represents a (C1-C4)alkyl group, a (C3-C6)cycloalkyl group, a halogen atom, a (C1-C5)alkoxy group, a -SO2-NRaRb group, a -SO3H group, a –OH group, a -O-SO2-ORc group or a -O-P(=O)-(ORc)(ORd) group, R1 represents (i) a CF3 group, (ii) a (C1-C10)alkyl group, (iii) a (C3-C6)cycloalkyl or a (C3- C6)heterocycloalkyl group or (iv) a phenyl group or a naphthyl group, and R2 represents a hydrogen atom, a (C1-C10)alkyl group, a (C3-C6)cycloalkyl or a (C3-C6)heterocycloalkyl group. The present invention further relates to new compounds, to pharmaceutical compositions containing them and to synthesis process for manufacturing them.